Table S2 from Copper Chelation as Targeted Therapy in a Mouse Model of Oncogenic BRAF-Driven Papillary Thyroid Cancer
Year: 2023
Type: other
Abstract: Days per week (up to 7) mice (1-10) were treated with vehicle, vemurafenib, or TM in the 8-week study.
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361817927
